Key result
Hybrid Phase II cardiac rehab sustains monthly enrollment above 70% in eligible men with CVD.
Why the study?
The COVID-19 pandemic halted approximately 75% of CR programmes globally, including phase II services in Qatar, prompting the implementation of a hybrid model to ensure continuation of care.
Does a hybrid Cardiac Rehabilitation Phase II exercise program achieve target enrollment and improve exercise capacity in eligible male patients with cardiovascular disease?
Does a hybrid Cardiac Rehabilitation Phase II exercise program achieve target enrollment and improve exercise capacity in eligible male patients with cardiovascular disease?
Implementing a hybrid cardiac rehabilitation program using quality improvement methodology is feasible, safe, and effective for maintaining patient enrollment and improving exercise capacity during pandemic disruptions.
Answers are grounded in this paper and cite their sources.
May support hybrid CR to sustain enrollment amid disruptions; leaves open efficacy confirmation in RCTs.
The COVID-19 pandemic resulted in the cessation of approximately 75% of cardiac rehabilitation (CR) programmes worldwide. In March 2020, CR phase II (CRP2) services were stopped in Qatar. Multiple studies had shown safety, effectiveness, reduced cost of delivery and improved participation with hybrid CR. A multidisciplinary team reviewed various alternative models for delivery and decided to implement a hybrid CRP2 exercise programme (HCRP2-EP) to ensure continuation of our patient care. Our aim was to enrol in the HCRP2-EP 70% of all eligible patients by 30 September 2020. Institute for Health Care Improvement's collaborative model was adopted. Multiple plan-do-study-act cycles were used to test change ideas. The outcomes of the project were analysed using standard run chart rules to detect the changes in outcomes over time. This project was implemented from March 2020, and the male patients enrolled between August 2020 and April 2021, with sustained monthly median enrolment above target of 70% throughout. As for our secondary outcome, 75.8% of the male patients who completed HCRP2-EP showed a meaningful change in peak exercise capacity of ≥10% (mean change 17%±6%). There were no major adverse events reported, and the median Patient Satisfaction Score was 96% well above the institutional target of 90%. This shows a well-designed quality improvement programme is an appropriate strategy for implementing HCRP2-EP in a clinical setting, and HCRP2-EP is a feasible, effective and safe intervention in eligible male patients with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Diaz et al. (2023) studied Cardiovascular disease. Hybrid Cardiac Rehabilitation Phase II exercise programme (HCRP2-EP) was evaluated on Enrolment of eligible patients. A hybrid Cardiac Rehabilitation Phase II exercise program achieved sustained monthly median enrollment above the 70% target in eligible male patients with cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: